Overview
- 127 inspections across 109 sites are on record.
- 410 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-12-20.
At a glance
Inspections
127
Sites
109
Observations
410
Career since
Jan 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Health Pharma USA LLC | 20 Dec 2022 | Human Drugs | View 483 → |
| Akorn Inc. | 17 May 2022 | Human Drugs | View 483 → |
| EuTech Scientific Services, Inc. | 28 Dec 2021 | Human Drugs | View 483 → |
| Novitium Pharma LLC | 8 Jul 2021 | Human Drugs | View 483 → |
| Willard Manufacturing Inc. | 6 Mar 2020 | Human Drugs | View 483 → |
Sites inspected
Health Pharma USA LLCRahway, United States1 insp.
Akorn Inc.Somerset, United States1 insp.
EuTech Scientific Services, Inc.Budd Lake, United States1 insp.
Novitium Pharma LLCEast Windsor, United States1 insp.
Willard Manufacturing Inc.Brampton, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Barbara J Wilimczyk-Macri11 shared
Adetutu M Gidado9 shared
Addam S Reynolds9 shared
Erin D Mccaffery8 shared
Frederick Razzaghi6 shared
Atul Agrawal6 shared
Juanita P Versace4 shared
Maria Estrella4 shared
Kristen E Rescigno4 shared
Jessica M Monteiro3 shared
Full investigator report
Get the verbatim findings behind Nicholas A Violand's 410 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site